1. Safeguard supports active surveillance as the preferred administration system for men with low-chance prostate cancer.seven Modern day Lively surveillance protocols differ slightly from your active monitoring strategy used in Guard. Some advancements in active surveillance that have arisen Because the trial period incorporate additional regimen usage of magnetic resonance https://www.directivepublications.org/annals-of-urology/